Appointments
- Lipoxen appoints Ajay Agrawal as head of business development
18 August 2008 - Former FDA chief counsel to join GlaxoSmithKline
16 August 2008 - Tatjana May to head Shire’s corporate responsibility committee
14 August 2008 - Colman Casey becomes non-executive director at Avecia Biologics
14 August 2008 - Nigel Burns appointed chairman of Cell Medica
14 August 2008 - Alan Goodman appointed to the supervisory board of Paion
03 August 2008 - Anne Fairey to become non-executive director at Biocompatibles
02 August 2008 - Paul Capital Partners promotes Ken Macleod
25 July 2008 - Evotec names the chairman of supervisory board
21 July 2008 - Antisoma appoints Michael Lewis as a non-executive director
14 July 2008 - Imperial Innovations appoints non-executive director
10 July 2008 - Lawrence Posner appointed to the board of NOXXON Pharma
09 July 2008 - Pharmexa appoints new CEO
05 July 2008 - Robin Wright joins Orexo
05 July 2008 - Exiqon appointments Cynthia French and Erik Holmlin
05 July 2008 - Willy De Greef appointed EuropaBio secretary general
30 June 2008 - BioAlliance appoints six new supervisory board members
17 June 2008 - Bernd Hentsch to become chief development officer at 4SC
17 June 2008 - Algeta appoints new chief financial officer
17 June 2008 - Ipsen appoints Gérard Picot to regulatory affairs job
17 June 2008 - Cyprotex appoints new chief executive
17 June 2008 - New non-executive directors at Elan
17 June 2008 - Amarin appoints investors as non-executive directors
17 June 2008 - Loic Maurel to become chief operating officer of ExonHit Therapeutics
17 June 2008 - Axel Mescheder appointed to MediGene board
17 June 2008 - Genmab appoints new chief financial officer
17 June 2008 - Simon Best awarded OBE for exceptional service
16 June 2008 - Affimed appoints Volker Lang as chief business officer
12 June 2008 - Shire appoints Graham Hetherington as CFO
12 June 2008 - PregLem appoints new CFO
31 May 2008 - Gerald Möller re-elected as chair of MorphoSys’s supervisory board
31 May 2008 - Pantec Biosolutions appoints new board members
31 May 2008 - UK appoints scientific advisor
31 May 2008 - NextGen Sciences makes appointments to boost its biomarker business
24 May 2008 - GlycoVaxyn appoints Philippe Dro as CEO
22 May 2008 - Cees de Jong to join management board of Crucell
19 May 2008 - Shire appoints Michael Rosenblatt as a non-executive director
29 April 2008 - Innate Pharma appoints senior US representative
24 April 2008 - Addex elects Raymond Hill to its board
22 April 2008 - Addex appoints Laurent Massuyeau as head of business development
22 April 2008 - IP Group appoints Francis Carpenter as a non-executive director
19 April 2008 - Asterand appoints Peter Coggins as non-executive director
08 April 2008 - Mats Berggren appointed CEO of SwedenBIO
04 April 2008 - Norman J. Ornstein to join UCB Board of Directors
04 April 2008 - EMEA makes appointments to CHMP and working parties
27 March 2008 - Syntaxin appoints Eduard Holdener as a non-executive director
22 March 2008 - Sygnis appoints Frank Rathgeb as chief medical officer
20 March 2008 - Ark Therapeutics appoints banker to its board
20 March 2008 - Alexander Lewis to be non-executive director at Oxford BioMedica
17 March 2008 - Sygnis appoints Peter Simon as VP for Business Development
03 March 2008 - Oxford Genome Sciences appoints Prof Elke Jaeger to science board
01 March 2008 - Bob Prachar to head US operations for Neuropharm Group
01 March 2008 - UK Medical Research Council names technology-transfer head
01 March 2008 - AstraZeneca appoints Jean-Philippe Courtois to its board
20 February 2008 - Biofrontera Pharma makes marketing and sales appointments
18 February 2008 - NOXXON Pharma appoints Frank Morich as CEO
18 February 2008 - Crucell nominates Steve Davis as supervisory board member
18 February 2008 - PCI Biotech appoints Per Walday as CEO
18 February 2008 - Synosia Therapeutics appoints first CFO
05 February 2008 - Peter Wulff to resign from Bavarian Nordic
28 January 2008 - New Chair for the UK’s Human Fertilisation and Embryology Authority
23 January 2008 - Gordon Duff is appointed chair of UK influenza advisory body
21 January 2008 - Hamish Cameron named partner at SV Life Sciences
21 January 2008 - Maria Dzaleta joins Neuropharm Group Plc
21 January 2008 - Newron Pharmaceuticals appoints Hans-Joachim Lohrisch to board
15 January 2008 - Frank Mathias to join the executive board of MediGene
03 January 2008 - Gitte Aabo becomes new CEO of LEO Pharma
03 January 2008 - Torsten Hombeck becomes CFO of GPC Biotech
03 January 2008 - Olof Tydén joins the board of BioXell
03 January 2008 - Ian Gilham becomes CEO of Axis-Shield
03 January 2008 - Thomas Lynch appointed CEO of Amarin
03 January 2008 - Genfit appoints Nathalie Huitorel as vice president for finance
28 December 2007 - Prof Alain Fischer joins Cellectis’s scientific advisory board
28 December 2007 - John Lechleiter to become CEO of Eli Lilly
20 December 2007 - Willem de Laat named managing director of TI Pharma
19 December 2007 - Karel Boone to become Chairman of UCB
19 December 2007 - Senior appointments at Novexel
19 December 2007 - Vinay Ranade appointed CEO at GeneMedix
18 December 2007 - Shire appoints Matthew Emmens as chairman and Angus Russell as CEO
13 December 2007 - Eduard Holdener to become chairman of NovImmune
06 December 2007 - Chris Brinsmead to head the ABPI
05 December 2007 - BTG appoints new chairman, John Brown
05 December 2007 - Nitec Pharma appoints Hans Fünfschilling as chairman
04 December 2007 - New head of business operations at Actelion
04 December 2007 - Christopher Christopher joins Oxford Genome Sciences board
03 December 2007 - Eden Biodesign restructures its executive management team
03 December 2007 - Stem Cell Sciences appoints new CEO
19 November 2007 - Molecular Partners appoints Jörn Aldag as chairman
15 November 2007 - CeNeS Pharmaceuticals appoints finance director
12 November 2007 - BIA appoints new chairman
09 November 2007 - Shire appoints David Mott as non executive director
06 November 2007 - New vice-chair for the EMEA’s Committee on Herbal Medicinal Products
01 November 2007 - ProStrakan appoints Peter Allen as chairman
30 October 2007 - Jeremy Scudamore becomes non-executive chairman of SkyePharma
18 October 2007 - Sir Walter Bodmer joins advisory board at Oxford Genome Sciences
18 October 2007 - Sir Leszek Borysiewicz appointed head of UK Medical Research Council
17 October 2007 - John Parsons named chief commercial officer at TopoTarget
17 October 2007 - NOXXON Pharma appoints Joachim Kempeni as CMO
10 October 2007 - Ardana appoints new CEO
08 October 2007 - AstraZeneca appoints new CFO
01 October 2007 - EMEA’s new paediatric committee elects chairman and vice-chairman
29 September 2007 - Sylvie Gregoire to head human genetic therapies business at Shire
24 September 2007 - Biotica Technology appoints new CEO
20 September 2007 - ProBioGen makes changes to business development team
20 September 2007 - Alistair McGregor becomes BIA finance director
20 September 2007 - Pharmexa appoints Achim Kaufhold as CSO and CMO
20 September 2007 - Algeta appoints Peter Harris as Chief Medical Officer
19 September 2007 - Clavis appoints Geir Christian Melen as CEO
19 September 2007 - Marc Jaeger elected president of the CFI
18 September 2007 - Ablynx appoints chief medical officer
11 September 2007 - DSM appoints group director of pharmaceutical products
10 September 2007 - Jado Technologies in Germany appoints new CEO
05 September 2007 - John Hutchinson leaves Vernalis
05 September 2007 - Egalet appoints new CEO
27 August 2007 - TheraGenetics appoints Dr Heiner Dreismann as chairman
17 August 2007 - Probiodrug appoints new chief financial officer
01 August 2007 - New chair and vice chair for EMEA scientific committee
19 June 2007 - Sareum appoints Giorgio Reggiani as finance director
18 June 2007 - BioIndustry Association executive awarded MBE
18 June 2007 - Probi AB appoints Michael Oredsson as CEO
13 June 2007 - EMEA elects veterinarian as management board chair
08 June 2007 - Santaris appoints biopharmaceutical executive as non-executive chairman
25 May 2007